The Drive
#246 - AMA #45: Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent
New
13 Mar 2023 · 27 min
Weight management
Play this episode
About this episode
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this "Ask Me Anything" (AMA) episode, Peter focuses the discussion on two topics getting a lot of attention recently. He first dives deep into GLP-1 agonists, most notably semaglutide and tirzepatide, which originally came to market as diabetes drugs but are now being studied and prescribed for weight loss. He walks through the data and compares the effectiveness